Seminars
May 22nd, 2026
Anna Blakney, PhD
Assistant Professor and Tier 2 Canada Research Chair at the Michael Smith Laboratories and School of Biomedical Engineering, University of British Columbia
Next-Generation RNA Vaccines & Therapies
Register
May 21st, 2026
Wayne Koff, PhD
Managing Partner, Next Frontier Advisors
Towards Development of Alzheimer’s Vaccines: The Alzheimer’s Vaccine Initiative
Register
April 14th, 2026
Virginia E. Kimonis, MD
Professor of Division of Genetics and Genomic Medicine, Pediatrics UCI School of Medicine
Challenges with Developing Promising Treatments for Rare Diseases
March 18th, 2026
Charles Glabe, PhD
Professor of Molecular Biology and Biochemistry UC Irvine Charlie Dunlop School of Biological Sciences
The Diversity of Naturally Occurring Antibodies Declines Dramatically in Alzheimer’s Disease
February 17th, 2026
Taishi Kimura, PhD
HDT Bio
LNP-Based Gene Editing for Glaucoma
January 20, 2026
Gulab Zode, PhD
Professor of Department of Physiology and Biophysics
LNP-Based Gene Editing for Glaucoma
November 19, 2025
Jeffrey Ulmer, PhD
President and CEO, TechImmune, LLC
Toward the Development of a Broad-Spectrum Pan-Beta Coronavirus Vaccine and an Immunotheraphy for the Prevention and Treatment of Long COVID
October 14, 2025
Andrew Geall, PhD
Co-founder and Chief Development Officer Replicate Bioscience
Reinventing the Gene Vaccine: 16 Years and Counting
September 9, 2025
Albert Jonathan Auguste, PhD
Associate Professor, Department of Entomology Virginia Polytechnic Institute and State University
The Tale of an Insect-Specific Flavivirus: from Ecology to Vaccine Development